Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 6
Submit an article Journal homepage
528
Views
0
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL

Niamh ApplebyDepartment of Haematology, St. James’s Hospital and Trinity College Dublin, Dublin, Ireland; Correspondence[email protected]
View further author information
,
David O’BrienDepartment of Haematology, St. James’s Hospital and Trinity College Dublin, Dublin, Ireland; View further author information
,
Fiona M. QuinnDepartment of Cancer Molecular Diagnostics, St. James’s Hospital, Dublin, Ireland; View further author information
,
Liam SmythDepartment of Haematology, St. James’s Hospital and Trinity College Dublin, Dublin, Ireland; View further author information
,
Johanna KellyDepartment of Medical Genetics, Our Lady's Hospital for Children, Dublin, Ireland; View further author information
,
Imelda ParkerCancer Trials Ireland, Dublin, Ireland; View further author information
,
Kathleen ScottCancer Trials Ireland, Dublin, Ireland; View further author information
,
Mary R. CahillDepartment of Haematology, Cork University Hospital, Cork, Ireland; View further author information
,
Gerard CrottyDepartment of Haematology, Midlands Regional Hospital, Tullamore, Ireland; View further author information
,
Helen EnrightDepartment of Haematology, Adelaide, Meath and National Children’s Hospital, Dublin, Ireland; View further author information
,
Brian HennessyDepartment of Haematology, University Hospital Waterford, Waterford, Ireland; View further author information
,
Andrew HodgsonDepartment of Haematology, Sligo Regional Hospital, Sligo, Ireland; View further author information
,
Maeve LeahyDepartment of Haematology, University Hospital Limerick, Limerick, Ireland; View further author information
,
Hilary O’LearyDepartment of Haematology, University Hospital Limerick, Limerick, Ireland; View further author information
,
Michael O’DwyerDepartment of Haematology, University Hospital Galway, Galway, IrelandView further author information
,
Amjad HayatDepartment of Haematology, University Hospital Galway, Galway, IrelandView further author information
&
Elisabeth A. VandenbergheDepartment of Haematology, St. James’s Hospital and Trinity College Dublin, Dublin, Ireland; View further author information
 show all
Pages 1338-1347 | Received 11 Jul 2017, Accepted 01 Sep 2017, Published online: 19 Sep 2017

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.